Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Children aged between 5 - 14 years of age with clinical features. 2 Children clinically diagnosed with epilepsy and verified with diagnostic parameters. 3 Children having frequency of seizural attacks not less than once in 30 days. 4 Patients who are on AEDs and facing cognitive, behavioural or psychological adverse effect without disturbing their regular medicine.
Exclusion criteria
Exclusion criteria: 1 Age 14 years. 2 Children not fulfilling the screening criteria. 3 Children with chronic ailments like tuberculosis, malignancy etc and any other congenital syndromic disorder. 4 Children having frequency of seizures attack one in more than 30 days. 5 Patients not regular in the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| THE RESEARCH DRUG IS EXPECTED TO BE BENEFICIAL FOR IMPROVING THE SYMPTOMS OF EPILEPSY LIKE FREQUENCY,SEVERITY , DURATION ETCTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| BY THE USE OF THIS GHRITA CHILD GROWS RAPIDLY AND SPEAKS PROPERLY,CURED DEPRESSION AND CALMS THE MINDTimepoint: 3 MONTHS | — |
Countries
India
Contacts
STATE AYURVEDIC COLLEGE AND HOSPITAL LUCKNOW UP